Cellular and synaptic mechanisms of nicotine addiction

Alkondon M, 1993, Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes, J Pharmacol Exp Ther, 265, 1455

10.1016/S0028-3908(00)00156-8

Alkondon M, 1997, Neuronal nicotinic acetylcholine receptor activation modulates gamma‐aminobutyric acid release from CA1 neurons of rat hippocampal slices, J Pharmacol Exp Ther, 283, 1396

Alkondon M, 1996, Alpha‐bungarotoxin‐sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release. J, Pharmacol Exp Ther, 278, 1460

10.1111/j.1360-0443.1991.tb01795.x

10.1016/S0014-2999(97)00101-5

10.1016/S0896-6273(00)81056-9

10.1523/JNEUROSCI.16-02-00714.1996

10.1523/JNEUROSCI.19-10-03723.1999

Breese CR, 1997, Effect of smoking history on [3H]nicotine binding in human postmortem brain, J Pharmacol Exp Ther, 282, 7

Broide RS, 1996, Regulation of alpha7 nicotinic acetylcholine receptors in the developing rat somatosensory cortex by thalamocortical afferents, J Neurosci, 16, 2956, 10.1523/JNEUROSCI.16-09-02956.1996

Buisson B, 2001, Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function, J Neurosci, 21, 1819, 10.1523/JNEUROSCI.21-06-01819.2001

10.1016/S0028-3908(00)00158-1

10.1111/j.1476-5381.1989.tb16873.x

10.1523/JNEUROSCI.20-10-03864.2000

10.1097/00001756-199809140-00033

Clarke PB, 1988, Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats, J Pharmacol Exp Ther, 246, 701

10.1007/BF02244174

10.1016/0006-8993(94)90401-4

10.1007/BF02245149

10.1016/S0891-0618(00)00110-1

10.1016/S0091-3057(01)00652-9

Dani JA, 1996, Molecular and cellular aspects of nicotine abuse, 10.1016/S0896-6273(00)80112-9

10.1016/S0896-6273(01)00379-8

10.1016/S0014-2999(00)00003-0

10.1007/s002130050214

10.1016/S0014-2999(00)00122-9

10.1073/pnas.85.14.5274

10.1136/tc.9.3.313

10.1016/0092-8674(94)90555-X

10.1073/pnas.051622798

10.1016/S0091-3057(01)00642-6

10.1523/JNEUROSCI.20-20-07855.2000

Fisher JL Pidoplichko VI Dani JA1998. Nicotine modifies the activity of ventral tegmental area dopaminergic neurons and hippocampal GABAergic neurons. J Physiol (Paris) 92:209–213.

Flores CM, 1991, A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is upregulated by chronic nicotine treatment, Mol Pharmacol, 41, 31

10.1523/JNEUROSCI.18-20-08228.1998

10.1523/JNEUROSCI.18-04-01187.1998

10.1038/18019

10.1002/(SICI)1096-9861(19990726)410:2<197::AID-CNE3>3.0.CO;2-D

10.1523/JNEUROSCI.21-14-05182.2001

Gourlay SG Benowitz NL1997. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking nicotine nasal spray and intravenous nicotine. Clin Pharmacol Ther 62:453–463.

10.1038/383713a0

Grottick AJ, 2000, Evidence that nicotinic alpha 7 receptors are not involved in the hyperlocomotor and rewarding effects of nicotine, J Pharmacol Exp Ther, 294, 1112

10.1016/S0168-0102(97)00074-6

10.1111/j.1469-7793.1999.769ab.x

10.1016/S0079-6123(08)63177-5

Henningfield JE Stapleton JM Benowitz NL Grayson RF London ED1993. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend 33:23–29.

10.1046/j.1471-4159.1997.69010137.x

Ikemoto S Murphy JM McBride W.J.1997b. Self‐infusion of GABA(A) antagonists directly into the ventral tegmental area and adjacent regions. Behav Neurosci 111:369–380.

10.1016/0014-2999(86)90629-1

10.1152/jn.2000.83.5.2682

10.1016/S0896-6273(01)00332-4

10.1113/jphysiol.1992.sp019136

10.1126/science.1329209

10.1111/j.1469-7793.1997.603bd.x

10.1016/0306-4522(93)90048-K

Kalivas PW, 1989, Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes, J Pharmacol Exp Ther, 251, 378

10.1523/JNEUROSCI.21-05-01452.2001

10.1016/S0091-3057(96)00438-8

10.1007/BF00215474

10.1113/jphysiol.1975.sp011103

10.1111/j.1471-4159.1989.tb09146.x

Lena C, 1997, Role of Ca2+ ions in nicotinic facilitation of GABA release in mouse thalamus, J Neurosci, 17, 576, 10.1523/JNEUROSCI.17-02-00576.1997

10.1523/JNEUROSCI.13-06-02680.1993

10.1007/978-1-4899-1775-1_10

10.1016/S0028-3908(98)00151-8

Lu Y, 1999, Desensitization of nicotinic agonist‐induce [3H]gamma‐aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists, J Pharmacol Exp Ther, 291, 1127

10.1016/S0896-6273(02)00625-6

10.1016/S0896-6273(00)00042-8

Marks MJ, 1993, Downregulation of nicotinic receptor function after chronic nicotine infusion, J Pharmacol Exp Ther, 266, 1268

Marks MJ, 1985, Time course study of the effects of chronic nicotine infusion on drug response and brain receptors J Pharmacol Exp Ther, 235, 619

10.1126/science.7569895

10.1146/annurev.ph.57.030195.002513

10.1523/JNEUROSCI.19-08-02887.1999

10.1016/0014-2999(87)90556-5

10.1016/S0014-2999(98)00084-3

10.1016/0304-3940(93)90641-W

10.1016/0006-8993(94)01286-Q

10.1038/35053570

10.1126/science.278.5335.58

Nisell M Nomikos GG Svensson TH1994. Systemic nicotine‐induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse 16:36–44.

Oakman SA Faris PL Kerr PE Cozzari C Hartman BK1995. Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci 15:5859–5869.

Olale F, 1997, Chronic nicotine exposure differentially affects the function of human alpha 3, alpha 4, and alpha 7 neuronal nicotinic receptor subtypes, J Pharmacol Exp Ther, 283, 675

10.1007/BF02246034

10.1016/S0301-0082(99)00045-3

10.1038/4691

10.1016/0140-6736(92)91600-D

10.1038/34413

10.1038/37120

10.1111/j.1749-6632.1999.tb11332.x

Rogers AT, 1997, Differential upregulation of alpha 7 and alpha 3 subunit‐containing nicotinic acetylcholine receptors in rat hippocampal and PC12 cell cultures, Biochem Soc Transact, 25, 544S, 10.1042/bst025544s

10.1111/j.1471-4159.1990.tb05802.x

10.1146/annurev.ne.16.030193.002155

10.1016/S0306-4522(97)00243-1

10.1016/S0306-4522(98)00114-6

10.1126/science.275.5306.1593

10.1111/j.1471-4159.1985.tb04005.x

10.1523/JNEUROSCI.13-02-00596.1993

10.1002/cne.903200202

10.1007/s002130050159

10.1016/S0892-0362(02)00199-X

10.1523/JNEUROSCI.18-19-08003.1998

10.1007/BF02245088

10.1016/0306-4522(92)90076-E

Sulzer D, 1998, Dopamine neurons make glutamatergic synapses in vitro

10.1046/j.1471-4159.1995.65031407.x

10.1016/S0301-0082(00)00033-2

10.1002/hipo.450050611

10.1038/35079077

10.1523/JNEUROSCI.19-21-09579.1999

10.1016/0304-3940(94)90428-6

10.1016/0306-4522(93)90558-W

10.1016/0306-4522(80)90071-8

10.1074/jbc.273.44.28721

10.1523/JNEUROSCI.16-08-02605.1996

WHO.1997. Tobacco or health a global status report. Geneva Switzerland: World Health Organization. Available through:http://www.who.int/.

WHO.1999. Combating the tobacco epidemic. In: The World Health report1999. Making a difference. Geneva Switzerland: World Health Organization. Available through:http://www.who.int/.

Wise R, 1987, A psychomotor stimulant theory of addiction, Psych Rev, 94, 469, 10.1037/0033-295X.94.4.469

WonnacottS.1997.Presynaptic nicotinic ACh receptors. Trends Neurosci.20:92–98.

10.1016/S0361-9230(00)00237-9

10.1046/j.1471-4159.1994.63010186.x

10.1038/nn769

10.1523/JNEUROSCI.15-03-01912.1995

10.1016/S0165-0173(97)00048-9